Hypothalamic regulation of feeding by nutrients and metabolic state;Regulación hipotalámica de la ingesta por nutrientes y estado metabólico

Revista Espanola de Obesidad

Volumn 5, Issue 6, 2007, Pages 351-362

  Mendieta Zerón, Hugo ^a   López, Miguel ^a   Diéguez, Carlos ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ARCUATE NUCLEUS; BRAIN FUNCTION; DIET; ENERGY BALANCE; FOOD INTAKE; FOOD PREFERENCE; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; MACRONUTRIENT; METABOLISM; NERVE CELL; REVIEW;

EID: 39149143294     PISSN: 16966112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Mutch DM, Wahli W, Williamson G. Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 2005; 19: 1602-16.
2. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Eodocrinology 1998; 139: 4428-31.
3. Harding R, Leek BF. Central projections of gastric afferent vagal inputs. J Physiol 1973; 228: 73-90.
4. Appleyard SM, Bailey TW, Doyle MW, Jin YH, Smart JL, Low MJ, et al. Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids. J Neurosci 2005; 25: 3578-85.
5. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med 2003; 54: 453-71.
6. Halford JC, Blundell JE. Pharmacology of appetite suppression. Prog Drug Res 2000; 54: 25-58.
7. Robbins TW. Hunger. In: Lighman S.L.& Everitt B (ed). Neuroendocrinology. Blackwell Scientific Publications 1986: 252-303.
8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
9. Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron 1999; 24: 941-51.
10. Lotter EC, Woods SC. Injections of insulin and changes of body weight. Physiol Behav 1977; 18: 293-97.
11. Knoll J. Satietin: a highly potent anorexogenic substance in human serum. Physiol Behav 1979; 23: 497-502.
12. Flier JS, Lowell B, Napolitano A, Usher P, Rosen B, Cook KS, et al. Adipsin: regulation and dysregulation in obesity and other metabolic states. Recent Prog. Horm. Res 1989; 45: 567-80.
13. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
14. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221(2): 286-9.
15. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 1999; 59: 4493-501.
16. Rodríguez DF, Navarro M, Gómez R, Escuredo L, Nava F, Fu J, et al. An anorexic lipid mediator regulated by feeding. Nature 2001; 414: 209-12.
17. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old. N Engl J Med 2006; 355: 763-78.
18. Wortley KE, Chang GQ, Davydova Z, Leibowitz SF. Peptides that regulate food intake: orexin gene expression is increased during states of hypertriglyceridemia. Am J Physiol Regul. Integr Comp Physiol. 2003; 284: R1454-R1465.
19. Lam TK, Pocai A, Gutiérrez-Juárez R, Obici S, Bryan J, Aguilar-Bryan L, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 2005; 11: 320-27.
20. Yun R, Dourmashkin JT, Hill JO, Gayles EC, Fried SK, Leibowitz SF. PVN galanin increases fat storage and promotes obesity by causing muscle to utilize carbohydrate more than fat. Peptides 2005; 26: 2265-73.
21. Beck B, Stricker-Krongrad A, Burlet A, Cumin F, Burlet C. Plasma leptin and hypothalamic neuropeptide Y and galanin levels in Long-Evans rats with marked dietary preferences, Nutr Neurosci 2001; 4: 39-50.
22. Stanley BG, Daniel DR, Chin AS, Leibowitz SF. Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 1985; 6: 1205-11.
23. Akabayashi A, Koenig JI, Watanabe Y, Alexander JT, Leibowitz SF. Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci USA 1994; 91: 10375-9.
24. Clegg DJ, Air EL, Woods SC, Seeley RJ. Eating elicited by orexin-A, but not melanin-concentrating hormone, is opioid mediated. Endocrinology 2002; 143: 2995-3000.
25. Chang GQ, Karatayev O, Davydova Z, Leibowitz SF. Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus. Endocrinology 2004; 145: 3904-12.
26. Leibowitz SF, Akabayashi A, Wang J. Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior para-ventricular nucleus projecting to the median eminence. J Neurosci 1998; 18: 2709-19.
27. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004; 305: 1733-6.
28. Lucas A. Programming by early nutrition: an experimental approach. J Nutr 1998; 128: 401S-6S.
29. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5-20.
30. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7: 847-54.
31. Ozanne SE, Hales CN. Lifespan: catch-up growth and obesity in male mice. Nature 2004: 427: 411-2.
32. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr 2004; 134: 2169-72.
33. Langley-Evans SC, Welham SJ, Sherman RC, Jackson AA. Weanling rats exposed to maternal low-protein diets during discrete periods of gestation exhibit differing severity of hypertension. Clin Sci (Lond) 1996; 91: 607-15.
34. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000; 279: E83-E87.
35. Ravelli G, Stein Z, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976; 295: 349-53.
36. Roseboom TJ, Van der Meulen JHP, Osmond C, Barker DJP, Ravelli ACJ, Tanka JS, et al. Coronary heart disease after prenatal exposure to the Dutch famine. Heart 2000; 84: 595-8.
37. Roseboom TJ, Van der Meulen JHP, Osmond C, Barker DJP, Ravelli ACJ, Bleker OP. Plasma lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr 2000; 72: 1101-6.
38. Ravelli ACJ, Van der Meulen JHP, Osmond C, Barker DJP, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr 1999; 70: 811-6.
39. Fleming TP, Kwong WY, Porter R, Ursell E, Fesenko I, Wilkins A, et al. The embryo and its future. Biol Reprod 2004; 71: 1046-54.
40. Lewis RM, Petry CJ, Ozanne SE, Hales CN. Effects of maternal iron restriction in the rat on blood pressure, glucose tolerance and serum lipids in the 3-month old offspring. Metabolism 2001; 50: 562-67.
41. Venu L, Harishankar N, Krishna TP, Raghunath M. Does maternal dietary mineral restriction per se predispose the offspring to insulin resistance? Eur J Endocrinol 2004; 151: 287-94.
42. Bouret SG, Draper SJ, Simerly RB. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci 2004; 24: 2797-805.
43. Grove KL, Smith MS. Ontogeny of the hypothalamic neuropeptide Y system. Physiol Behav 2003; 79: 47-63.
44. Cramer CP, Blass EM. Nutritive and nonnutritive determinants of milk intake of suckling rats. Behav Neurosci 1985; 99: 578-82.
45. Broberger C, Johansen J, Brismar H, Johansson C, Schalling M, Hökfelt T. Changes in neuropeptide Y receptors and proopiomelanocortin in the anorexia (anx/anx) mouse hypothalamus. J Neurosci 1999; 19: 7130-9.
46. Plagemann A, Harder T, Janert U, Rake A, Rittel F, et al. Malformations of hypothalamic nuclei in hyperinsulinemic offspring of rats with gestational diabetes. Dev Neurosci 1999; 21: 58-67.
47. Huizinga CT, Oudejans CBM, Delemarre-van de Waal HA. Persistent changes in somatostatin and neuropeptide Y mRNA levels but not in growth hormone-releasing hormone mRNA levels in adult rats after intrauterine growth retardation. J Endocrinol 2001; 168: 273-81.
48. Plagemann A, Harder T, Rake A, Melchior K, Rittel F, et al. Hypothalamic insulin and neuropeptide Y in the offspring of gestational diabetic mother rats. NeuroReport 1998; 9: 4069-73.
49. Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin North Am 2001; 30: 765-85.
50. Levin BE, Govek E. Gestational obesity accentuates obesity in obesity-prone progeny. Am J Physiol 1998; 275: R1374-9.
51. Dabelea D, Hanson RL, Lindsay RS, Pettit DJ, Imperatore G, Gabir MM, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000; 49: 2208-11.
52. Dorner G, Plagemann A. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm. Metab Res 1994; 26: 213-21.
53. Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G. Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding, Exp. Clin Endocrinol 1992; 99: 154-8.
54. Knittle J, Hirsch J. Effect of early nutrition on the development of rat epididymal fat pads: cellularity and metabolism. J Clin Invest 1968; 47: 2091.
55. Miller DS, Parsonage SR. The effect of litter size on subsequent energy utilization. Proc Nutr Soc 1972; 31: 30A.
56. Kozak R, Burlet A, Burlet C, Beck B. Dietary composition during fetal and neonatal life affects neuropeptide Y functioning in adult offspring. Brain Res Dev Brain Res 2000; 125: 75-82.
57. Kozak R, Richy S, Beck B. Persistent alterations in neuropeptide Y release in the paraventricular nucleus of rats subjected to dietary manipulation during early life. Eur J Neurosci 2005; 21: 2887-92.
58. Beck B, Kozak R, Moar KM, Mercer JG. Hypothalamic orexigenic peptides are overexpressed in young Long-Evans rats after early life exposure to fat-rich diets. Biochemical and Biophysical Research Communications 2006; 342: 452-8.
59. Manning J, Vehaskari VM. Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition. Am J Physiol Regul Integr Comp Physiol 2005; 288: R80-R84.
60. Vickers MH, Ikenasio BA, Breier BH. IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 2001; 142: 3964-73.
61. Wyrwoll CS, Mark PJ, Mori TA, Puddey IB, Waddell BJ. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology 2006; 147: 599-606.
62. Gidding SS, Dennison BA, Birch LL, Daniels SR, Gilman MW, Lichtenstein AH, et al; American Heart Association; American Academy of Pediatrics. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation 2005; 112: 2061-75. Erratum in: Circulation 2005; 112: 2375.
63. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1):S5-20.
64. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005; 142: 403-11.
65. Srinivasan M, Aalinkeel R, Song F, Patel MS. Programming of islet functions in the progeny of hyperinsulinemic/obese rats. Diabetes 2003; 52: 984-90.
66. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest 2001; 108: 1079-85. doi: 10.1172/JCI200112954.
67. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 1994; 43: 764-9.
68. Pocai A, Lam TK, Gutiérrez-Juárez R, Obici S, Schwartz GJ, Bryan J, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005; 434: 1026-31.
69. Adrian TE, Bacarese-Hamilton AJ, Smith HA, Chohan P, Manolas KJ, Bloom SR. Distribution and postprandial release of porcine peptide YY. J Endocrinol 1987; 113: 11-4.
70. Lundberg JM, Tatemoto K, Terenius L, Hellstrom PM, Mutt V, Kokfelt T, et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 1982; 79: 4471-5.
71. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 2001; 108: 635-6.
72. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
73. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001; 98: 9116-21.
74. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 2004; 101: 7281-6.
75. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-6.
76. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001; 86: 355-62.
77. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-55.
78. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30: 620-50.
79. Milagro FI, Campeón J, Martínez JA. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring). 2006; 14: 1118-23.
80. Pocai A, Lam TKT, Obici S, Gutiérrez-Juárez R, Muse ED, Arduini A, Rossetti L. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 2006; 116: 1081-91. doi:10.1172/JCI26640.
81. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, et al. Reduced atrerosclerosis in MyD88-null mice liks elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004; 10: 416-21.
82. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 2004; 18: 2024-34.
83. Moustaid N, Beyer RS, Sul HS. Identification of an insulin response element in the fatty acid synthase promoter. J Biol Chem 1994; 269: 5629-34.
84. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA 2004; 101: 15597-602.
85. Xiong S, Chirala SS, Hsu MH, Wakil SJ. Identification of thyroid hormone response elements in the human fatty acid synthase promoter. Proc Natl Acad Sci USA 1998; 95: 12260-5.
86. Clarke SD, Armstrong MK, Jump DB. Dietary polyunsaturated fats uniquely suppress rat liver fatty acid synthase and S14 mRNA content. J Nutr 1990; 120: 225-31.
87. Bennett MK, López JM, Sánchez HB, Osborne TF. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J Biol Chem 1995; 270: 25578-83.
88. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997; 244: 1-14.
89. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB, et al. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP activated protein kinase in rat tissues in response to exercise. J Biol Chem 2002; 277: 32571-7.
90. López M, Lelliott CJ, Tovar S, Kimber W, Gallego R, Virtue S, et al. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 2006; 55: 1327-36.
91. Hu Z, Cha SH, Van Haasteren G, Wang J, Lane MD. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. Proc Natl Acad Sci USA 2005; 102: 3972-7.
92. Cha SH, Hu Z, Chohnan S, Lane MD. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc Natl Acad Sci USA 2005; 102: 14557-62.
93. Martin TL, Alquier T, Asakura K, Furukawa N, Preitner F, Kahn BB. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem 2006; 281: 18933-41.
94. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, et al. J. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004; 279: 12005-8.
95. Bensaid A, Tomé D, Gietzen D, Even P, Morens C, Gausseres N, et al. Protein is more potent than carbohydrate for reducing appetite in rats. Physiol. Behav 2002; 75: 577-82.
96. Jean C, Rome S, Mathe V, Huneau JF, Aattouri N, Fromentin G, et al. Metabolic evidence for adaptation to a high protein diet in rats. J Nutr 2001; 131: 91-8.
97. Olszewski PK, Wirth MM, Shaw TJ, Grace MK, Levine AS. Peptides that regulate food intake: effect of peptide histidine isoleucine on consummatory behavior in rats. Am J. Physiol 2003; 284: R1445-R453.
98. Petrovich GD, Setlow B, Holland PC, Gallagher M. Amygdalohypothalamic circuit allows learned cues to override satiety and promote eating. J Neurosci 2002; 22: 8748-53.
99. Darcel N, Fromentin G, Raybould HE, Gougis S, Gietzen DW, Tome D. Fos-positive neurons are increased in the nucleus of the solitary tract and decreased in the ventromedial hypothalamus and amygdala by a high-protein diet in rats. J Nutr 2005; 135: 1486-90.
100. Konturek SJ, Meyers CA, Kwiecien N, Obtulowicz W, Tasler J, Oleksy J, et al. Effect of human pancreatic polypeptide and its C-terminal hexapeptide on pancreatic secretion in man and in the dog. Scand J Gastroenterol 1982; 17: 395-9.
101. Thor PJ, Konturek JW, Konturek SJ. Pancreatic polypeptide and intestinal motility in dogs. Dig Dis Sci 1987; 32: 513-19.
102. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003; 88: 3989-92.
103. Nguyen TT. The cholesterol-lowering action of plant stanol esters. J Nutr 1999; 129: 2109-12.
104. Law M. Plant sterol and stanol margarines and health. Br Med J 2000; 320: 861-4.
105. Grobbee DE. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Br Med J 1994; 309: 436-40.
106. Itoh K, Kawasaki T. Effect of low sodium, high potassium and high magnesium salt intake on blood pressure and lipid metabolism. J Jpn Soc Nutr Food Sci 1998; 51: 1-7.
107. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
108. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetología 1990; 33: 511-4.
109. Garfinkel D, Garfinkel L. Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium 1988; 7: 249-61.
110. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004; 17: 126-36.
111. Barbagallo M, Domínguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003; 24: 39-52.
112. Yacowitz H, Fleischman AI, Bierenbaum ML. Effects of oral calcium upon serum lipids in man. Br Med J 1965; 1: 1352-4.
113. Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 1993; 123: 1047-53.
114. Jeyakumar SM, Vajreswari A, Giridharan NV. Chronic dietary vitamin A supplementation regulates obesity in an obese mutant WNIN/Ob rat model. Obesity (Silver Spring). 2006; 14: 52-9.
115. Billaudel B, Barakat L, Faure-Dussert A. Vitamin D3 deficiency and alterations of glucose metabolism in rat endocrine pancreas. Diabetes Metab 1998; 24: 344-50.
116. Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1, 25-dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 1999; 160: 87-95.
117. Norman AW, Frankel BJ, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823-5.
118. Bourlon PM, Faure-Dussert A, Billaudel B, Sutter BC, Tramu G, Thomasset M. Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1, 25-dihydroxyvitamin D3. J Endocrinol 1996; 148: 223-32.
119. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. Faseb J 2003; 17: 509-11.